The Pro12Ala polymorphism of the PPAR-γ2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism

European Journal of Clinical Nutrition

Volumn 62, Issue 12, 2008, Pages 1432-1439

  Ylonen S K ^a,b   Salminen, I ^c   Lyssenko, V ^d   Virtanen, S M ^c,e,f   Groop, L ^d   Aro, A ^c   Saloranta, C ^b,g  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FOLKHÄLSAN RESEARCH CENTER   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d LUND UNIVERSITY   (Sweden)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f UNIVERSITY OF TAMPERE   (Finland)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CHOLESTEROL ESTER; DOCOSAHEXAENOIC ACID; GLUCOSE; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROLINE;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETOGENESIS; DIET RESTRICTION; DIETARY INTAKE; FAT INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; FISH; GAS CHROMATOGRAPHY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOMOZYGOTE; HUMAN; INSULIN RESISTANCE; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE;

ALANINE; ALLELES; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIET RECORDS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, NONESTERIFIED; FATTY ACIDS, OMEGA-3; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PPAR GAMMA; PROLINE; SEX FACTORS;

EID: 57449103940     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602882     Document Type: Article

References (49)

1. Adler AI, Boyko EJ, Schraer CD, Murphy NJ (1994). Lower prevalence of impaired glucose tolerance and diabetes associated with daily seal oil or salmon consumption among Alaska Natives. Diabetes Care 17 1498-1501.
2. Alberti KGMM, Zimmet PZ, for the WHO Consultation (1998). Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabetic Med 15, 539-553.
3. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl M-C, Nemesh J et al. (2000). The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26 76-80. (Letter).
4. Andersson A, Nälsén C, Tengblad S, Vessby B (2002). Fatty acid composition of skeletal muscle reflects dietary fat composition in humans. Am J Clin Nutr 76, 1222-1229.
5. Auwerx J (1999). PPARγ, the ultimate thrifty gene. Diabetologia 42, 1033-1049.
6. Baur LA, O'Connor J, Pan DA, Kriketos AD, Storlien LH (1998). The fatty acid composition of skeletal muscle membrane phospholipid: Its relationship with the type of feeding and plasma glucose levels in young children. Metabolism 47, 106-112.
7. Bjerregaard P, Pedersen HS, Mulvad G (2000). The associations of a marine diet with plasma lipids, blood glucose, blood pressure and obesity among the Inuit in Greenland. Eur J Clin Nutr 54, 732-737.
8. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV (1993). The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 328 238-244.
9. 13C]α-linolenic acid to longer-chain fatty acids and partitioning towards β-oxidation in older men. Br J Nutr 90, 311-321.
10. Dewailly É, Blanchet C, Gingras S, Lemieux S, Sauvé L, Bergeron J et al. (2001a). Relations n-3 fatty acid status and cardiovascular disease risk factors among Quebecers. Am J Clin Nutr 74, 603-611.
11. Dewailly E, Blanchet C, Lemieux S, Sauvé L, Gingras S, Ayotte P et al. (2001b). n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am J Clin Nutr 74, 464-473.
12. Ek J, Andersen G, Urhammer SA, Hansen L, Carstensen B, Borch-Johnsen K et al. (2001). Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPAR-γ2) gene in relation to insulin sensitivity among glucose tolerant Caucasians. Diabetologia 44, 1170-1176.
13. Ekblond A, Mellemkjær L, Tjønneland A, Suntum M, Stripp C, Overvad K et al. (2000). A cross-sectional study of dietary habits and urinary glucose excretion - a predictor of non-insulin-dependent diabetes mellitus. Eur J Clin Nutr 54, 434-439.
14. Feskens EJM, Bowles CH, Kromhout D (1991). Inverse association between fish intake and risk of glucose intolerance in normoglycemic elderly men and women. Diabetes Care 14, 935-941.
15. Feskens EJM, Virtanen SM, Räsänen L, Tuomilehto J, Stengård J, Pekkanen J et al. (1995). Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care 18, 1104-1112.
16. Folch J, Lees M, Stanley GHS (1957). A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226, 497-507.
17. González Sánchez JL, Serrano Ríos M, Fernández Pérez C, Laakso M, Martínez Larrad MT (2002). Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated γ-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur J Endocrinol 147, 495-501.
18. Gustafsson I-B, Öhrvall M, Ekstrand B, Vessby B (1998). No effects on insulin sensitivity but diverging effects on serum free fatty acid concentrations by addition of seafood products containing n-3 or n-6 fatty acids. Nutr Metab Cardiovasc Dis 8, 145-153.
19. Harding A-H, Day NE, Khaw K-T, Bingham SA, Luben RN, Welsh A et al. (2004). Habitual fish consumption and glycated haemoglobin: The EPIC-Norfolk Study. Eur J Clin Nutr 58, 277-284.
20. Hu FB, van Dam RM, Liu S (2001). Diet and risk of type II diabetes: The role of types of fat and carbohydrate. Diabetologia 44, 805-817.
21. 13C nuclear magnetic resonance study. Diabetes 48 134-140.
22. Lindi V, Schwab U, Louheranta A, Laakso M, Vessby B, Hermansen K et al. (2003). Impact of the Pro12Ala polymorphism of the PPAR-γ2 gene on serum triacylglycerol response n-3 fatty acid supplementation. Mol Genet Metab 79, 52-60.
23. Liu S, Baracos VE, Quinney HA, Clandinin MT (1994). Dietary ω-3 and polyunsaturated fatty acids modify fatty acyl composition and insulin binding in skeletal-muscle sarcolemma. Biochem J 299, 831-837.
24. Lopes SM, Trimbo SL, Mascioli EA, Blackburn GL (1991). Human plasma fatty acid variations and how they are related to dietary intake. Am J Clin Nutr 53, 628-637.
25. Luan J, Browne PO, Harding A-H, Halsall DJ, O'Rahilly S, Chatterjee VKK et al. (2001). Evidence for gene-nutrient interaction at the PPARγ locus. Diabetes 50, 686-689.
26. Ma J, Folsom AR, Shahar E, Eckfeldt JH, for the Atherosclerosis Risk in Communities (ARIC) Study investigators (1995). Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. Am J Clin Nutr 62, 564-571.
27. Marshall JA, Bessesen DH, Hamman RF (1997). High saturated fat and low starch and fibre are associated with hyperinsulinaemia in a non-diabetic population: The San Luis Valley Diabetes Study. Diabetologia 40 430-438.
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985). Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
29. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD et al. (2000). Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 71, 1085-1094.
30. Mori Y, Murakawa Y, Katoh S, Hata S, Yokoyama J, Tajima N et al. (1997). Influence of highly purified eicosapentaenoic acid ethyl ester on insulin resistance in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus. Metabolism 46, 1458-1464.
31. North KE, Franceschini N, Borecki IB, Gu CC, Heiss G, Province MA et al. (2007). Genotype-by-sex interaction on fasting insulin concentration. The HyperGEN Study. Diabetes 56, 137-142.
32. Pan DA, Lillioja S, Milner MR, Kriketos AD, Baur LA, Bogardus C et al. (1995). Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest 96, 2802-2808.
33. Pawlosky R, Hibbeln J, Lin Y, Salem Jr N (2003). n-3 Fatty acid metabolism in women. Br J Nutr 90, 993-995. (Letter).
34. Pighin D, Karabatas L, Rossi A, Chicco A, Basabe JC, Lombardo YB (2003). Fish oil affects pancreatic fat storage, pyruvate dehydrogenase complex activity and insulin secretion in rats fed a sucroserich diet. J Nutr 133, 4095-4101.
35. Risérus U, Tan GD, Fielding BA, Neville MJ, Currie J, Savage DB et al. (2005). Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans. Link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-γ. Diabetes 54, 1379-1384.
36. Salmerón J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, Rimm EB et al. (2001). Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 73, 1019-1026.
37. Salomaa V, Ahola I, Tuomilehto J, Aro A, Pietinen P, Korhonen HJ et al. (1990). Fatty acid composition of serum cholesterol esters in different degrees of glucose intolerance: A population-based study. Metabolism 39, 1285-1291.
38. Stoffel W, Chu F, Ahrens Jr EH (1959). Analysis of long-chain fatty acids by gas-liquid chromatography. Anal Chem 31, 307-308.
39. Stumvoll M, Häring H (2002). The peroxisome proliferator-activated receptor-γ2 Pro12Ala polymorphism. Diabetes 51, 2341-2347.
40. Stumvoll M, Wahl HG, Löblein K, Becker R, Machicao F, Jacob S et al. (2001). Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ2 gene is associated with increased antilipolytic insulin sensitivity. Diabetes 50, 876-881.
41. Thorsdottir I, Hill J, Ramel A (2004). Omega-3 fatty acid supply from milk associates with lower type 2 diabetes in men and coronary heart disease in women. Prev Med 39, 630-634.
42. van Dam RM, Willett WC, Rimm EB, Stampfer MJ, Hu FB (2002). Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 25, 417-424.
43. Vessby B, Aro A, Skarfors E, Berglund L, Salminen I, Lithell H (1994a). The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 43, 1353-1357.
44. Vessby B, Tengblad S, Lithell H (1994b). Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 37, 1044-1050.
45. Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC et al. (2001). Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study. Diabetologia 44, 312-319.
46. Wang L, Folsom AR, Zheng Z-J, Pankow JS, Eckfeldt JH, for the ARIC Study investigators (2003). Plasma fatty acid composition and incidence of diabetes in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 78, 91-98.
47. Willett W, Stampfer MJ (1986). Total energy intake: Implications for epidemiologic analyses. Am J Epidemiol 124, 17-27.
48. Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ et al. (1999). Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 3, 397-403.
49. Ylönen K, Saloranta C, Kronberg-Kippilä C, Groop L, Aro A, Virtanen SM et al. (2003). Associations of dietary fiber with glucose metabolism in nondiabetic relatives of subjects with type 2 diabetes. The Botnia Dietary Study. Diabetes Care 26, 1979-1985.